STOCK TITAN

Phathom Pharmaceuticals to Participate in Two Upcoming Investor Healthcare Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Phathom Pharmaceuticals (Nasdaq: PHAT) announced participation in two upcoming virtual investor conferences. The first, Guggenheim Healthcare Talks, is scheduled for November 16, 2021, at 9:40 am EST. The second event, Jefferies London Healthcare Conference, will take place on November 17, 2021, at 5:00 am EST / 10:00 am GMT. Management will also engage in one-on-one meetings during the conferences. Webcast details and recordings will be available for 90 days on Phathom's website.

Positive
  • None.
Negative
  • None.

FLORHAM PARK, N.J., Nov. 12, 2021 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, announced today that members of its management team will participate at two upcoming virtual investor conferences, including:

Guggenheim Healthcare Talks: 3rd Annual Neuro/Immunology Conference
Date: November 16, 2021
Live Webcast: 9:40 am EST

Jefferies London Healthcare Conference
Date: November 17, 2021
Fireside Chat: 5:00 am EST / 10:00 am GMT

Members of Phathom’s management team will also participate virtually in one-on-one meetings throughout the duration of each conference.

To access the live webcast and archived recording of the presentations, visit the News & Events section of the Phathom website at https://investors.phathompharma.com/news-events/events-and-presentations. The recordings will be available for 90 days following the events.

About Phathom Pharmaceuticals, Inc.
Phathom Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of novel treatments for gastrointestinal diseases and disorders. Phathom has in-licensed the exclusive rights in the United States, Europe, and Canada to vonoprazan, a novel potassium competitive acid blocker (P-CAB) in late-stage development for the treatment of acid-related disorders. For more information about Phathom, visit the Company’s website at www.phathompharma.com and follow the Company on LinkedIn and Twitter.

CONTACTS
Media Contact:
Nick Benedetto
1-877-742-8466
media@phathompharma.com

Investor Contact:
Joe Hand
1-877-742-8466
ir@phathompharma.com


FAQ

What dates will Phathom Pharmaceuticals participate in investor conferences in November 2021?

Phathom Pharmaceuticals will participate in investor conferences on November 16 and 17, 2021.

What time will Phathom present at the Guggenheim Healthcare Talks conference?

Phathom will present at the Guggenheim Healthcare Talks on November 16, 2021, at 9:40 am EST.

What is the schedule for the Jefferies London Healthcare Conference for Phathom Pharmaceuticals?

Phathom will present at the Jefferies London Healthcare Conference on November 17, 2021, at 5:00 am EST / 10:00 am GMT.

Where can I access the webcasts and recordings of Phathom's presentations?

The webcasts and recordings can be accessed on Phathom's website under the News & Events section.

How long will the recorded presentations from Phathom Pharmaceuticals be available?

The recorded presentations will be available for 90 days after the events.

Phathom Pharmaceuticals, Inc.

NASDAQ:PHAT

PHAT Rankings

PHAT Latest News

PHAT Stock Data

1.25B
68.29M
8.83%
96.44%
23.91%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
FLORHAM PARK